Über WordPress
WordPress.org
Dokumentation (engl.)
Learn WordPress
Support
Feedback
Anmelden
Registrieren
Veranstaltungen
Kalender anzeigen
Suchen
Zum Inhalt springen
German
German
English
Spanish
French
Chinese
Arabic
Japanese
Russian
Turkish
Ukrainian
Urdu
Vietnamese
Portuguese
Marathi
Korean
Kazakh
Indonesian
Hindi
Dutch
Bengali
Login
Become a Member
Suche
Search
About MPS
Close About MPS
Open About MPS
MPS Types
MPS I
(Hurler, Hurler-Scheie, Scheie Syndrome)
MPS II
(Hunter Syndrome)
MPS III
(Sanfilippo Syndrome)
MPS IV
(Morquio Syndrome)
MPS VI
(Maroteaux-Lamy Syndrome)
MPS VII
(Sly Syndrome)
ML II and ML III
(I-Cell Disease and Pseudo-Hurler Polydystrophy)
Educational Resources
Booklets & Guides
Videos
Archive
Courage Pages
MPS Treatments
Clinical Trials
Emerging Treatments
ERT
Get Support
Close Get Support
Open Get Support
Get Support
Newly Diagnosed
Become a Member
Membership Renewal
Support Programs
What We Do
Close What We Do
Open What We Do
What We Do
About Us
Meet Our Team
Our History
Financial Reports
Contact Us
Fundraise
Get Involved
Close Get Involved
Open Get Involved
Get Involved
Spenden Sie
Advocate
Volunteer
Shop
News & Events
Close News & Events
Open News & Events
News & Events
News
Events
Living With Courage Blog
Podcast
Research
Close Research
Open Research
Research
Research Grants
Spenden Sie
About MPS
MPS Types
MPS Treatments
Booklets & Guides
Videos
Archive
Courage Pages
Get Support
Newly Diagnosed
Become a Member
Membership Renewal
Support Programs
What We Do
About Us
Meet Our Team
Our History
Financial Reports
Contact Us
Get Involved
Spenden Sie
Advocate
Volunteer
Shop
News & Events
News
Events
Living With Courage Blog
Podcast
Research
Research Grants
Spenden Sie
Fundraise
Startseite
Suche
Search
Facebook
Instagram
Linkedin
Youtube
X-twitter
Login
ML II/III | Libretes
Mai 5, 2023
ML II/III
Click here to download.
Back to Archive
More From the Archives
AAV2/8-mediated expression of modified sulphamidase, liver targeting for improved secretion and brain delivery in IIIA Huntaway dog.
Read More
Gene Therapy for MPS IVA
Read More
Therapeutic Targeting of Wnt/β-Catenin Signaling to Improve Bone Formation in MPS VII
Read More
Targeting mTORCI and autophagy pathways to rescue the skeletal phenotype in MPS mouse models
Read More
Validation of small molecule therapeutic leads for treatment of MPS I disease
Read More
Englisch
Englisch
Deutsch
Spanisch
Französisch
Italienisch
Polnisch
Schwedisch
Finnisch
Portugiesisch
Rumänisch
Slowenisch
Slowakisch
Niederländisch
Dänisch
Griechisch
Tschechisch
Ungarisch
Litauisch
Lettisch
Estnisch
Kroatisch
Irisch
Bulgarisch
Norsk
Türkçe
Bahasa Indonesia
Português (Brasil)
日本語
한국어
简体中文
العربية
Русский
हिन्दी
Українська
Srpski
Barrierefreiheit-Anpassungen
Unterstützt von
OneTap
Hide Toolbar
Back
How long do you want to hide the accessibility toolbar?
Hide Toolbar Duration
Only for this session
24 hours
A Week
Not Now
Hide Toolbar
Wählen Sie Ihr Barrierefreiheitsprofil
Modus für Sehbehinderte
Verbessert die visuelle Darstellung der Website
Profil für Anfallssicherheit
Beseitigt Blitze und reduziert Farben
ADHD-freundlicher Modus
Fokussiertes Surfen, ohne Ablenkungen
Blindenmodus
Reduziert Ablenkungen, verbessert den Fokus
Epilepsie-sicherer Modus
Dämpft Farben und stoppt das Blinken
Inhalt
Größerer Text
Cursor
Zeilenhöhe
Buchstabenabstand
Lesbare Schriftart
Schriftart für Legastheniker
Text ausrichten
Textlupe
Links hervorheben
Farben
Farben umkehren
Helligkeit
Kontrast
Graustufen
Sättigung
Orientierung
Leselinie
Tastaturnavigation
Titel hervorheben
Lesemaske
Bilder ausblenden
Alles hervorheben
Browser needs to be updated
Your browser doesn’t support speech output. Please update your browser or use one with speech synthesis enabled (e.g. Chrome, Edge, Safari).
How to Update?
Seite vorlesen
Töne stummschalten
Animationen stoppen
Einstellungen zurücksetzen
German
English
Spanish
French
Chinese
Arabic
Japanese
Russian
Turkish
Ukrainian
Urdu
Vietnamese
Portuguese
Marathi
Korean
Kazakh
Indonesian
Hindi
Dutch
Bengali
